DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...
Researchers are trialling the use of cell therapy used in cancer treatment, in the hope it could offer a possible cure for those with the illness. | ITV National News ...
ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.
A recent report by the US Geological Survey (USGS) shows that much of Connecticut’s public groundwater supply areas, including areas that provide water to the state's largest cities, have a high ...